ZA961412B - A method for the isolation and purification of lipid cell-wall components - Google Patents

A method for the isolation and purification of lipid cell-wall components

Info

Publication number
ZA961412B
ZA961412B ZA961412A ZA961412A ZA961412B ZA 961412 B ZA961412 B ZA 961412B ZA 961412 A ZA961412 A ZA 961412A ZA 961412 A ZA961412 A ZA 961412A ZA 961412 B ZA961412 B ZA 961412B
Authority
ZA
South Africa
Prior art keywords
derivatives
salts
mycolic acids
isolation
purification
Prior art date
Application number
ZA961412A
Other languages
English (en)
Inventor
Jan Adrianus Verschoor
Original Assignee
Adcock Ingram Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adcock Ingram Ltd filed Critical Adcock Ingram Ltd
Publication of ZA961412B publication Critical patent/ZA961412B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409—Fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1289—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C12P7/6445—Glycerides
    • C12P7/6463—Glycerides obtained from glyceride producing microorganisms, e.g. single cell oil
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00—Technologies for the production of fuel of non-fossil origin
    • Y02E50/10—Biofuels, e.g. bio-diesel

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
ZA961412A 1995-02-22 1996-02-22 A method for the isolation and purification of lipid cell-wall components ZA961412B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA951464 1995-02-22

Publications (1)

Publication Number Publication Date
ZA961412B true ZA961412B (en) 1996-08-26

Family

ID=25584852

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA961412A ZA961412B (en) 1995-02-22 1996-02-22 A method for the isolation and purification of lipid cell-wall components

Country Status (12)

Country Link
US (1) US6171830B1 (de)
EP (1) EP0811075B1 (de)
JP (1) JPH11500906A (de)
CN (1) CN1183811A (de)
AT (1) ATE395428T1 (de)
AU (1) AU720288B2 (de)
CA (1) CA2213428A1 (de)
DE (1) DE69637522D1 (de)
HU (1) HUP9900378A3 (de)
RU (1) RU2155230C2 (de)
WO (1) WO1996026288A1 (de)
ZA (1) ZA961412B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU726734B2 (en) * 1996-11-13 2000-11-16 Centenary Institute Of Cancer Medicine & Cell Biology Mycobacterium cell wall compositions
AUPO359396A0 (en) 1996-11-13 1996-12-05 Amrad Operations Pty. Limited A method of treatment and pharmaceutical compositions useful for same
CN1057077C (zh) * 1998-05-12 2000-10-04 中国医学科学院医药生物技术研究所 一种具有免疫抑制作用的化合物
CA3116307C (en) 2010-02-23 2023-10-17 University Of Washington Artificial mycolic acid membranes
ES2631556T3 (es) * 2011-01-04 2017-09-01 Archivel Farma, Sl Formulación de liposomas adecuada para tratar o prevenir la tuberculosis
WO2013104943A1 (en) 2012-01-12 2013-07-18 Archivel Farma, S.L. Mtb-c vaccine against asthma

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877612A (en) * 1985-05-20 1989-10-31 Frank M. Berger Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
EP0261248B1 (de) * 1986-03-20 1991-05-29 Sawai Pharmaceutical Co., Ltd. -g(a), -g(a)-trehalose trimycolat und arzneimittelzubereitung
WO1995000163A1 (en) * 1993-06-21 1995-01-05 Brigham And Women's Hospital Methods of isolating cd1-presented antigens, vaccines comprising cd1-presented antigens, and cell lines for use in said methods
BR9507389A (pt) * 1994-04-14 1997-09-16 Adcock Ingram Ltd Método para detectar a presença de uma espécie mycobacterium e um kit e anticorpos para uso no mesmo

Also Published As

Publication number Publication date
HUP9900378A2 (hu) 1999-05-28
AU720288B2 (en) 2000-05-25
EP0811075A1 (de) 1997-12-10
EP0811075B1 (de) 2008-05-14
RU2155230C2 (ru) 2000-08-27
AU4728796A (en) 1996-09-11
WO1996026288A1 (en) 1996-08-29
DE69637522D1 (de) 2008-06-26
JPH11500906A (ja) 1999-01-26
CA2213428A1 (en) 1996-08-29
CN1183811A (zh) 1998-06-03
ATE395428T1 (de) 2008-05-15
HUP9900378A3 (en) 1999-11-29
US6171830B1 (en) 2001-01-09

Similar Documents

Publication Publication Date Title
DE59608686D1 (de) Verfahren zur Entfernung von unerwünschten lipophilen Verunreinigungen und/oder Rückständen, welche in Getränken oder pflanzlichen Zubereitungen enthalten sind
FI945186A (fi) Uusi uuttomenetelmä luonnossa esiintyvien makrolidien talteenottamiseksi
MY141766A (en) Extraction process for removal of impurities from an aqueous mixture
WO2000078741A3 (en) Process for extraction and purification of paclitaxel from natural sources
ATE203057T1 (de) Verfahren zur industriellen herstellung von phosphatidylserine
SE8402861L (sv) Rening av biologiskt material
ZA961412B (en) A method for the isolation and purification of lipid cell-wall components
WO1994008708A3 (en) Compositions of fatty acid esters of hexitans
ATE147066T1 (de) Verfahren zum abtrennen von aminosäuren aus wässrigen lösungen
FR2670771B1 (de)
BR8306875A (pt) Processo para a purificacao de acido fosforico em processo por via umida
GB2343786A (en) Order charge separation and order-charge type separation
BR9714138A (pt) Processo para a cristalização por suspensão.
DE68928249D1 (de) Verfahren zur Trennung von Methylester von alpha-L-aspartyl-L-phenylalaninen
DE3763068D1 (de) Verfahren zur abtrennung und reinigung organischer substanzen von begleitstoffen.
Leybros Process for extracting and concentrating cadmium in low and intermediate concentrations in concentrated sulphuric effluents
HK1005027A1 (en) Process for purification of 1,2-bis(nicotinamido) propane
TH1802B (th) กรรมวิธีของการผลิตสตีวิโอไซต์บริสุทธิ์
JPS5612339A (en) Purification of trimethoxybenzoic acid
TH933A (th) กรรมวิธีของการผลิตสตีวิโอไซต์บริสุทธิ์